Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

India

 

Carlyle acquires Knack RCM and EqualizeRCM

US private equity firm Carlyle has acquired a majority stake in two healthcare revenue cycle management (RCM) platforms: Knack RCM and EqualizeRCM. The investment is being made through Carlyle Asia Partners VI and Carlyle Asia Partners Growth II.
May 7, 2026

Sun Pharma acquires US-based Organon

Sun Pharmaceutical, India’s largest drug maker by revenue, has agreed to acquire US-listed Organon, which has a portfolio of therapies and products in women’s health, biosimilars and established medicines, for an enterprise value of $11.7 billion. This marks the largest overseas acquisition by an Indian pharmaceutical company to date.
April 30, 2026

Novartis sells Indian arm to PE as big pharma pivots to specialty medicines

Global pharma is increasingly viewing emerging markets in three segments, retaining operations hubs and premium specialty markets while exiting older, mass‑market generics. European companies are divesting legacy portfolios to focus on high-growth biologics and precision medicines.
February 26, 2026

KKR leads bid for Star Hospitals, consolidating India’s private hospital sector

Indian multi-speciality hospital group Baby Memorial Hospital (BMH), backed by US private equity firm KKR, is reportedly the leading bidder to acquire Hyderabad-based cardiovascular chain Star Hospitals. The offer is said to value the group at ~₹2,700 crore (~ $302 million). Fortis Hospitals, a for-profit private network with around 6,000 beds, has also been reported as a potential contender, but reports in the Indian media indicate that KKR is the front-runner.
November 27, 2025

Verlinvest invests $75m in The Eye Foundation

Verlinvest, the Belgium-based family investment firm, has invested $75 million for a minority stake in The Eye Foundation, an Indian ophthalmology chain with more than 25 hospitals across southern India.
October 30, 2025

Indian eyewear retailer Lenskart targets $960 million IPO

The south Asian country’s healthcare and consumer tech sectors are seeing a surge in IPOs, reflecting strong investor confidence. For European investors, India offers selective opportunities in diagnostics, specialty hospitals, medtech, and senior care, promising high returns when paired with experienced local partners.
October 16, 2025

Tensions between Indian providers and insurers “likely to continue” in the near term

Long-standing tensions between private Indian healthcare providers and insurers erupted into a major stand-off over the past two weeks. Many North Indian providers unilaterally decided to suspend cashless treatment for people insured by Bajaj Allianz, one of India’s biggest health insurers, because of complaints that claims were not being settled on time. This dispute has now been resolved, but we hear such tensions between providers and payors are a widespread issue in the Indian market and likely to continue in the near term.
September 4, 2025
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us